Common OR (95% CI) | Adjusted common odds ratio (95% CI)* | |
Model 1 | ||
Any intracranial hemorrhage | 0.31 (0.25 to 0.39) | 0.59 (0.46 to 0.76) |
Model 2 | ||
Asymptomatic intracranial hemorrhage | 0.44 (0.35 to 0.57) | 0.76 (0.58 to 0.98) |
Symptomatic intracranial hemorrhage | 0.04 (0.02 to 0.07) | 0.07 (0.04 to 0.14) |
Model 3 | ||
Isolated hemorrhagic infarction type 1 | 0.61 (0.42 to 0.89) | 0.76 (0.51 to 1.13) |
Isolated hemorrhagic infarction type 2 | 0.54 (0.36 to 0.82) | 1.00 (0.64 to 1.56) |
Isolated parenchymal hematoma type 1 | 0.32 (0.17 to 0.59) | 0.67 (0.35 to 1.30) |
Isolated parenchymal hematoma type 2 | 0.12 (0.06 to 0.27) | 0.37 (0.14 to 0.95) |
Isolated subarachnoid hemorrhage | 0.44 (0.25 to 0.77) | 0.55 (0.30 to 1.03) |
Other isolated hemorrhage (SDH/IVH/rPH) | 0.35 (0.12 to 1.01) | 0.50 (0.17 to 1.49) |
Combined hemorrhagic infarction with hemorrhage outside infarcted brain tissue | 0.23 (0.13 to 0.42) | 0.52 (0.27 to 1.03) |
Combined parenchymal hematoma with hemorrhage outside infarcted brain tissue | 0.06 (0.04 to 0.10) | 0.17 (0.10 to 0.30) |
Combined hemorrhages outside infarcted brain tissue | 0.20 (0.04 to 1.02) | 0.14 (0.03 to 0.74) |
Effect estimates are presented as common odds ratios (OR) and adjusted common odds ratios (aOR) with 95% confidence intervals (CI). The reference for all models was ‘no intracranial hemorrhage’.
*Adjusted for age, sex, pre-stroke mRS score, history of hypertension, history of diabetes mellitus, history of myocardial infarction, prior use of antithrombotics, baseline NIHSS score, door intervention center to groin puncture time, intravenous thrombolytics, post-EVT eTICI score, final infarct volume, periprocedural treatment with aspirin, and periprocedural treatment with unfractionated heparin.
eTICI, extended thrombolysis in cerebral infarction; EVT, endovascular treatment; IVH, intraventricular hemorrhage; mRS, modified Rankin Scale; NIHSS, National Institutes of Health Stroke Scale; rPH, remote parenchymal hematoma; SDH, subdural hematoma.